The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
Open accessAbstract
THE development of a vaccine to provide protective immunity to human immunodeficiency virus type 1 (HIV-1), the virus causing AIDS, would be the most practical method to control its spread. Subunit vaccines consisting of virus envelope glycoproteins, produced by recombinant DNA technology, are effective in preventing viral infections1. We have now used this approach in the development of a candidate AIDS vaccine. Chimpanzees were immunized with recombinant forms of the HIV-1 glycoproteins gp120 and gp160 produced in Chinese hamster ovary cells, and then challenged with HIV-1. The control and the two animals immunized with the gp160 variant became infected within 7 weeks of challenge. The two animals immunized with the gp120 variant have shown no signs of infection after more than 6 months. These studies demonstrate that recombinant gp120, formulated in an adjuvant approved for human use, can elicit protective immunity against a homologous strain of HIV-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Self-citationRusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R., Langlois, A., Gallo, R. C., Arthur, L. O., & Fischinger, P. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3198 · Cited by 620
Immunology: The ins and outs of antigen processing and presentations
Germain, R. N. (1986) · Nature · doi:10.1038/322687a0 · Cited by 496
ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
Robinson, W. E., Montefiori, D., & Mitchell, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91657-1 · Cited by 358
Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., & Berman, P. W. (1986) · Science · doi:10.1126/science.3014647 · Cited by 353
Self-citationThe Fc and not CD4 Receptor Mediates Antibody Enhancement of HIV Infection in Human Cells
Homsy, J., Meyer, M., Tateno, M., Clarkson, S., & Levy, J. A. (1989) · Science · doi:10.1126/science.2786647 · Cited by 330
Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA
Scolnick, E. M. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03340450028021 · Cited by 164
Prince, A. M., Horowitz, B., Baker, L., Shulman, R. W., Ralph, H., Valinsky, J., Cundell, A., Brotman, B., Boehle, W., & Rey, F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6944 · Cited by 161
Berman, P. W., Groopman, J. E., Gregory, T. J., Clapham, P. R., Weiss, R. A., Ferriani, R. A., Riddle, L. M., Shimasaki, C. D., Lucas, C., & Lasky, L. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5200 · Cited by 143
Self-citationRobinson, W. E., Kawamura, T., Górny, M. K., Lake, D. F., Xu, J. Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, W. M., & Hersh, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3185 · Cited by 122
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines
Arthur, L. O., Bess, J. W., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J.-C., & Henderson, L. E. (1992) · Science · doi:10.1126/science.1470916 · Cited by 559
Shibata, R., Igarashi, T., Haigwood, N., Buckler–White, A., Ogert, R., Ross, W., Willey, R., Cho, M. W., & Martin, M. A. (1999) · Nature Medicine · doi:10.1038/5568 · Cited by 539
Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody
Emini, E. A., Schleif, W. A., Nunberg, J. H., Conley, A. J., Eda, Y., Tokiyoshi, S., Putney, S. D., Matsushrta, S., Cobb, K. E., Jett, C. M., et al. (1992) · Nature · doi:10.1038/355728a0 · Cited by 471
Self-citationRoben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V., Self, S. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428405 · Cited by 355
Self-citationImmunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., & Muchmore, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.542 · Cited by 352
Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160
Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R., & Benveniste, R. E. (1992) · Science · doi:10.1126/science.1531159 · Cited by 335
André, S., Seed, B., Eberle, J., Schraut, W., Bültmann, A., & Haas, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1497-1503.1998 · Cited by 305
Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N., Smith, G. L., Watkins, D. I., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7524-7532.1999 · Cited by 304
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M. T., Goletti, D., Baroncelli, S., Pace, M., Sernicola, L., Koanga-Mogtomo, M. L., Betti, M., et al. (1999) · Nature Medicine · doi:10.1038/9488 · Cited by 276
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
Fauci, A. S., Schnittman, S. M., Poli, G., Koenig, S., & Pantaleo, G. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-678 · Cited by 273
The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection
Epstein, F. H., Epstein, F. H., & Greene, W. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240506 · Cited by 273
Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine
Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., & Eldridge, J. H. (1993) · Science · doi:10.1126/science.8493576 · Cited by 261
Immunopathogenesis of HIV Infection
Fox, L. M. (2002) · Immunotherapy for Infectious Diseases · doi:10.1007/978-1-59259-171-8_8 · Cited by 254
An Assessment of the Role of Chimpanzees in AIDS Vaccine Research
Bailey, J. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600403 · Cited by 49
Metadata
- Authors
- Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., & Eichberg, J. W.
- Venue
- Nature
- Published
- 1990-06-14
- Volume
- 345
- Issue
- 6276
- Pages
- 622-625
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049836668
- Cited by
- 590
- References
- 13
- FWCI
- 22.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.